- Report
- May 2023
- 120 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- September 2022
- 87 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- September 2022
- 114 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- October 2025
- 24 Pages
Greece
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 22 Pages
Portugal
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 21 Pages
Uruguay
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 26 Pages
Malaysia
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 21 Pages
Denmark
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 52 Pages
Bangladesh
From €2150EUR$2,595USD£1,932GBP
- Report
- October 2025
- 21 Pages
Sweden
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 24 Pages
Slovakia
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 21 Pages
Slovenia
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 80 Pages
Slovenia
From €2675EUR$3,228USD£2,404GBP
- Report
- October 2025
- 103 Pages
Slovakia
From €2675EUR$3,228USD£2,404GBP
- Report
- October 2025
- 23 Pages
Romania
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 25 Pages
Peru
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 22 Pages
Israel
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 21 Pages
Latvia
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 97 Pages
Israel
From €2675EUR$3,228USD£2,404GBP
- Report
- October 2025
- 108 Pages
Peru
From €2675EUR$3,228USD£2,404GBP

Allergic Rhinitis is a condition that affects the nose and is caused by an allergic reaction to certain substances. Over the Counter (OTC) drugs are used to treat the symptoms of Allergic Rhinitis, such as sneezing, runny nose, and itchy eyes. OTC drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. Common active ingredients in OTC drugs for Allergic Rhinitis include antihistamines, decongestants, and corticosteroids. These drugs can be used to reduce inflammation, relieve congestion, and reduce the severity of symptoms.
Some companies in the Allergic Rhinitis Drug market include Johnson & Johnson, GlaxoSmithKline, Novartis, Merck, and Sanofi. Show Less Read more